CLARITY MEDICAL (01406) appoints Chito Consultants as independent special committee forensic advisors.
Clear Medical (01406) issued an announcement that, in accordance with the resumption guidance, the company must conduct an independent forensic investigation into the allegations and related matters, evaluate the impact on the company's business operations and financial condition, disclose the results, and take appropriate corrective measures.
After considering the backgrounds, experiences, and professional knowledge of several candidates, the Independent Special Committee recommended to the Board of Directors the appointment of Chengtong Consulting Services Limited (Chengtong Consulting) as the forensic advisor for the Independent Special Committee, to conduct an independent forensic investigation into the allegations of significant misstatement in the listing prospectus, and report the results and conclusions of the investigation to the Independent Special Committee and the Board of Directors. The appointment of Chengtong Consulting has been approved by the Board of Directors.
CLARITY MEDICAL (01406) announced that, in accordance with the resumption guidelines, the company must conduct an independent forensic investigation into the allegations and related matters, evaluate the impact on the company's operations and financial condition, publish the results, and take appropriate corrective actions.
After considering the backgrounds, experiences, and professional knowledge of several candidates, the Independent Special Committee recommended that the Board appoint Deloitte Consulting Services Limited (Deloitte Consulting) as the forensic consultant for the Independent Special Committee to conduct an independent forensic investigation into the allegations of significant misstatements in the prospectus, and report the findings and conclusions to the Independent Special Committee and the Board. The appointment of Deloitte Consulting has been approved by the Board.
Related Articles

IFBH(06603) spent 1.099 million Hong Kong dollars to repurchase 90,200 shares on March 5th.

PRADA (01913) will distribute a final dividend of 0.166 euros per share on May 19th.

BRETON (01333) enters into a General Contract for the Construction of the Gancunruvaxis Digital Energy Project with a capital of approximately $17.08 million.
IFBH(06603) spent 1.099 million Hong Kong dollars to repurchase 90,200 shares on March 5th.

PRADA (01913) will distribute a final dividend of 0.166 euros per share on May 19th.

BRETON (01333) enters into a General Contract for the Construction of the Gancunruvaxis Digital Energy Project with a capital of approximately $17.08 million.

RECOMMEND





